Products
Online Inquiry
PSB-CB5
Inquiry
Cat. No.:
OB0125LY-041
Synonyms:
1627710-30-8; PSB CB5; (2Z)-2-[[3-[(4-Chlorophenyl)methoxy]phenyl]methylidene]-6,7-dihydro-5H-imidazo[2,1-b][1,3]thiazin-3-one; (2Z)-2-((3-((4-Chlorophenyl)methoxy)phenyl)methylene)-6,7-dihydro-5H-imidazo(2,1-b)(1,3)thiazin-3(2H)-one; 5H-Imidazo(2,1-b)(1,3)thiazin-3(2H)-one, 2-((3-((4-chlorophenyl)methoxy)phenyl)methylene)-6,7-dihydro-, (2Z)-; (Z)-2-(3-((4-Chlorobenzyl)oxy)benzylidene)-6,7-dihydro-2H-imidazo[2,1-b][1,3]thiazin-3(5H)-one; (Z)-2-(3-((4-Chlorobenzyl)oxy)benzylidene)-6,7-dihydro-5H-imidazo[2,1-b][1,3]thiazin-3(2H)-one
Size:
1 mg; 5 mg; 10 mg
CAS No.:
1627710-30-8
Compound CID:
85469571
Specification
Description:
PSB-CB5 is a potent and selective GRP18 antagonist.
Formula Weight:
384.88
Applications:
PSB-CB5 can be used for metabolic disease and obesity research.
Storage:
Storage at -80°C.
Formula:
C20H17ClN2O2S
Appearance:
Solid
Purity:
≥95.0%
Solubility:
DMSO
Pathway:
GPCR/G Protein; Neuronal signaling
Target:
Cannabinoid receptor
Library Information
Solubility:
DMSO